Tower Research Capital LLC (TRC) - GLYCOMIMETICS INC ownership

GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 59 filers reported holding GLYCOMIMETICS INC in Q4 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of GLYCOMIMETICS INC
ValueSharesWeighting
Q1 2024$70,866
+941.8%
23,622
+719.6%
0.00%
Q4 2023$6,802
-2.7%
2,882
-38.2%
0.00%
Q3 2023$6,993
-53.4%
4,662
-45.9%
0.00%
Q2 2023$14,993
+49876.7%
8,617
-64.7%
0.00%
-100.0%
Q1 2023$30
-99.8%
24,441
+13.3%
0.00%
Q3 2022$12,000
+100.0%
21,577
+125.4%
0.00%
Q2 2022$6,000
+200.0%
9,574
+380.6%
0.00%
Q1 2022$2,000
-80.0%
1,992
-72.6%
0.00%
Q4 2021$10,000
-9.1%
7,272
+43.8%
0.00%
Q3 2021$11,000
-69.4%
5,056
-68.0%
0.00%
-100.0%
Q2 2021$36,000
+33.3%
15,784
+76.2%
0.00%
Q1 2021$27,000
+68.8%
8,956
+99.2%
0.00%
Q4 2020$16,000
-87.2%
4,497
-88.9%
0.00%
-100.0%
Q3 2020$125,000
+363.0%
40,648
+451.8%
0.00%0.0%
Q2 2020$27,000
-56.5%
7,367
-37.4%
0.00%
-80.0%
Q4 2019$62,000
+1.6%
11,773
-15.9%
0.01%
+25.0%
Q3 2019$61,000
+2950.0%
14,001
+7635.4%
0.00%
Q2 2019$2,000
-88.9%
181
-87.4%
0.00%
-100.0%
Q1 2019$18,000
-25.0%
1,432
-15.1%
0.00%
-50.0%
Q3 2018$24,000
-80.3%
1,687
-77.6%
0.00%
-80.0%
Q1 2018$122,000
+2950.0%
7,523
+2782.4%
0.01%
+900.0%
Q4 2017$4,000
-94.0%
261
-95.6%
0.00%
-87.5%
Q2 2017$67,000
+1240.0%
5,973
+553.5%
0.01%
Q1 2017$5,000
+66.7%
914
+88.1%
0.00%
Q4 2016$3,000
+50.0%
486
+128.2%
0.00%
Q3 2016$2,000
-66.7%
213
-77.7%
0.00%
-100.0%
Q1 2016$6,000
+20.0%
957
+8.4%
0.00%0.0%
Q4 2015$5,000
-58.3%
883
-58.4%
0.00%0.0%
Q3 2015$12,0002,1220.00%
Q2 2015$00
-100.0%
0.00%
Q1 2015$010.0%0.00%
Q4 2014$0
-100.0%
1
-99.4%
0.00%
Q3 2014$1,000
-92.3%
172
-77.7%
0.00%
-100.0%
Q1 2014$13,0007700.00%
Other shareholders
GLYCOMIMETICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
BVF INC/IL 7,361,801$38,944,0002.95%
NEA Management Company, LLC 9,089,041$48,081,0002.27%
Camber Capital Management LP 3,500,000$18,515,0000.94%
Redmile Group, LLC 1,343,845$7,109,0000.17%
CAXTON CORP 25,748$136,0000.13%
Alambic Investment Management, L.P. 15,210$80,0000.07%
Virtus ETF Advisers LLC 69,120$366,0000.06%
OXFORD ASSET MANAGEMENT LLP 133,008$704,0000.02%
AXA S.A. 1,890,492$10,002,0000.02%
Athanor Capital, LP 59,572$315,0000.01%
View complete list of GLYCOMIMETICS INC shareholders